Pacing is indicated when symptoms are directly attributable to a low heart rate. Symptoms include:
- Syncope (sudden loss of consciousness)
- Pre-syncope (near-fainting, lightheadedness)
- Dizziness or persistent fatigue
- Heart failure exacerbation due to low rate
- Chronotropic incompetence (failure to raise HR with exertion)
Dysfunction of the sinoatrial (SA) node resulting in abnormal impulse generation. Also known as sinus node dysfunction (SND).
| Manifestation | ECG Feature | Significance |
|---|---|---|
| Sinus Bradycardia | HR <60 bpm, normal P-wave morphology | Symptomatic requires pacing |
| Sinus Arrest | Pause >3 sec, no P-wave | Syncope risk — pacing indicated |
| Sinoatrial Block | Dropped P-wave, pause = multiple of PP interval | Symptomatic requires pacing |
| Tachy-Brady Syndrome | Alternating SVT/AF then sinus pause | Drug therapy + pacing required |
| Chronotropic Incompetence | Failure to reach 85% max HR with exercise | Rate-responsive pacing (VVIR/DDDR) |
| Degree | ECG Criteria | Clinical Action |
|---|---|---|
| 1st Degree | PR interval >200 ms (0.20 sec), all P-waves conduct | No treatment required. Monitor. Usually benign. |
| 2nd Degree Mobitz I (Wenckebach) | Progressive PR lengthening → dropped QRS; then cycle resets. AV node level block. | Usually benign, often vagal/inferior MI. Atropine if symptomatic. Rarely requires pacing. |
| 2nd Degree Mobitz II | Fixed PR interval with intermittent non-conducted P-waves. His-Purkinje level block. Unpredictable progression. | Permanent pacemaker indicated. Risk of progression to complete block. Temp pacing if acute. |
| 3rd Degree / Complete Block | Complete AV dissociation — P-waves and QRS independent. Ventricular escape (wide) or junctional escape (narrow). | EMERGENCY pacemaker. Transcutaneous pacing immediately, bridge to transvenous/permanent. |
A 5-letter code describing pacemaker programming. The first three positions are most commonly used clinically.
| Mode | Description | Use Case |
|---|---|---|
| VVI | Ventricular paced, ventricular sensed, inhibited. Single chamber backup pacing. | AF with bradycardia, SSS in AF |
| VVIR | VVI + rate responsive (accelerometer). Increases rate with activity. | Chronotropic incompetence, active patients |
| DDD | Dual chamber: tracks atrial rate, paces ventricle after AV delay. Physiological. | AV block with normal sinus function |
| DDDR | DDD + rate responsive. | AV block + chronotropic incompetence |
| VOO | Asynchronous ventricular pacing at fixed rate. Ignores intrinsic activity. | Magnet mode, EMI environments, pacemaker-dependent patients |
| AAI | Atrial paced/sensed/inhibited. Requires intact AV conduction. | SSS with normal AV conduction |
A programmed feature where the escape interval after a sensed beat is longer than the basic pacing interval. Allows intrinsic rhythm to predominate while ensuring backup pacing activates at a slower rate. Preserves natural AV synchrony.
Example
Pacing rate = 60 bpm (1000 ms). Hysteresis rate = 50 bpm (1200 ms). The device waits 1200 ms for intrinsic beat but will pace at 1000 ms once pacing begins.
The "R" suffix in VVIR/DDDR means the pacemaker uses a sensor to increase heart rate in response to physiological demand.
- Accelerometer: detects body movement/vibration
- Minute ventilation sensor: detects respiratory rate
- Mixed sensors: more physiological response
- Critical for patients with chronotropic incompetence
- Rate response can be inappropriately triggered by vibration (air travel, road travel)
- Acute complete (3rd degree) heart block
- Symptomatic 2nd degree Mobitz II block
- Symptomatic bradycardia unresponsive to atropine
- Post-cardiac surgery bradycardia (epicardial wires)
- Drug toxicity (digoxin, beta-blocker, CCB)
- Bridge to permanent pacemaker implantation
- Overdrive pacing for refractory VT/torsades
- Apply pads in antero-posterior (AP) position: anterior pad left parasternal V3-V4 position; posterior pad left infrascapular
- Set mode to DEMAND (synchronised to intrinsic activity) unless cardiac arrest → FIXED
- Start output at 70–80 mA; increase by 10 mA increments until capture
- Set rate 60–80 bpm (higher if haemodynamically compromised)
- Typical capture threshold: 50–100 mA
Mechanical capture: Palpate a femoral or carotid pulse — do NOT rely on ECG alone due to muscle artifact. Use pulse oximetry waveform or arterial line if available.
- Set output 10 mA above threshold once capture confirmed
- Monitor BP, SaO2 and patient comfort continuously
- Plan urgent transvenous pacing — TCP is a bridge only
- Preferred access: right internal jugular vein (IJV) — most direct route to RV
- Alternatives: subclavian, femoral (higher displacement risk)
- Lead advanced under fluoroscopy to RV apex
- Position confirmed: lead tip at apex with slight curve, pacing threshold <1 V, R-wave >5 mV
- Balloon-tipped (Swan-Ganz style) electrode can be floated without fluoroscopy
| Parameter | Initial Setting | Target |
|---|---|---|
| Rate | 60–70 bpm | Haemodynamically appropriate |
| Output (mA) | 5 mA | 2–3× threshold mA |
| Sensitivity (mV) | 2–3 mV | Adjust to suppress pacing with intrinsic beats |
| Mode | Demand (VVI) | VOO only if no intrinsic activity |
- Stimulation threshold: Reduce output slowly until capture is lost → threshold = last mA with capture. Set output at 3× threshold (safety margin)
- Sensing threshold: Reduce sensitivity (increase mV value) until device starts pacing through intrinsic beats → threshold = mV at that point. Set at 50% of threshold
- Document thresholds every shift and report rising thresholds (suggests lead dislodgement)
- Secure external lead connections with tape — prevent accidental disconnection
- Avoid kinking or tension on the pacing wire
- Sterile dressing changes every 24–48 h
- Limit patient mobility — educate patient on movement restrictions
- Label lead clearly: "PACEMAKER WIRE — DO NOT REMOVE"
- Loss of capture: Increase output → check connections → check lead position on CXR → consider reposition
- Failure to pace (no spikes): Check battery, connections, sensing threshold (over-sensing inhibiting output)
- Over-sensing: Reduce sensitivity (increase mV number) → reduces detection of extraneous signals
- Under-sensing: Increase sensitivity (reduce mV number) → better detection of intrinsic beats
Document that patient/family understands the following risks:
- Infection: ~1% (pocket infection to endocarditis)
- Pneumothorax: 1–2% (subclavian approach higher)
- Lead dislodgement: 2–5% (within first weeks)
- Pericardial effusion/tamponade: <1%
- Haematoma: pocket haematoma, especially with anticoagulation
- Venous thrombosis at access site
- Antibiotics: Cephalosporin (cefazolin 1–2 g) IV 30 minutes pre-procedure — reduces pocket infection risk by ~50%
- Anticoagulation: INR target <2.0 for warfarin; DOAC: hold 24–48 h depending on agent and CrCl
- Skin preparation: Electrical hair clipper — NEVER razor (micro-abrasions increase infection risk)
- NPO: 6 hours for solids, 2 hours for clear fluids
- IV access: Contralateral arm to implant side
- Baseline 12-lead ECG, CXR, FBC, U&E, coagulation screen
- Consent signed and documented
Procedure Summary (for nursing knowledge)
Performed in catheter lab / EP lab under local anaesthesia ± sedation. Duration 45–90 minutes.
| Step | Detail |
|---|---|
| Venous Access | Subclavian, cephalic, or axillary vein — left side preferred. Cephalic vein cut-down has lowest pneumothorax risk. |
| Lead Insertion | VVI: single RV lead. DDD: atrial lead (RA appendage) + ventricular lead (RV apex or RVOT for physiological pacing). |
| Fluoroscopic Guidance | Lead positions confirmed under X-ray. RV lead tip at apex shows left-lateral, inferior, and slightly anterior position. |
| Testing | Stimulation threshold, sensing amplitude, and impedance measured for each lead before securing. |
| Pocket Formation | Subcutaneous (subpectoral for thin patients) pocket in infraclavicular region. Device secured, wound closed in layers. |
| Device Implanted | Generator connected to leads, programmed to appropriate mode (DDD/VVI etc.). |
- Continuous cardiac monitoring — confirm pacing mode active, appropriate capture and sensing
- CXR within 2 hours post-procedure: confirm lead position AND exclude pneumothorax
- Vital signs every 30 min × 4, then hourly
- Wound inspection: haematoma, bleeding, dehiscence
- Observe for signs of cardiac tamponade: hypotension, JVP rise, muffled heart sounds
- Pressure dressing for first 12–24 hours
- Keep wound dry for 5–7 days
- Haematoma: manual compression first; if tense/enlarging → surgical drainage
- Infection signs: redness, warmth, swelling, discharge, fever — escalate immediately
- Wound review at 7–10 days
- Provide device identification card — patient carries at all times
- Follow-up appointment at 4–6 weeks for device check
- Arm restriction instructions written and verbal
- Driving restriction: typically 1 week (non-commercial) — check local regulations
- Electromagnetic interference (EMI) education
- MRI labelling: MRI conditional vs MRI non-conditional
- MRI conditional: Can undergo MRI under specified conditions (1.5T, specific SAR, specific mode). Requires pre-MRI device programming by EP team.
- MRI non-conditional / legacy devices: MRI contraindicated — risk of lead heating, reed switch activation, programming changes
- Always check device documentation — patient card shows MRI status
- All implant dates after ~2013: likely MRI conditional — verify with manufacturer
- Retail anti-theft devices (EAS systems) — walk through quickly, do not linger
- Strong industrial magnets, arc welding equipment
- Airport security: inform staff, request manual screening (wand may be used briefly)
- Mobile phones: hold to opposite ear, keep 15 cm from device
- Cautery (surgical diathermy): inform surgical team — use bipolar/lowest effective setting
- TENS machines, therapeutic ultrasound directly over device site
| Category | Criteria |
|---|---|
| Secondary Prevention | Survived VF or haemodynamically unstable VT not due to reversible cause; sustained VT with structural heart disease |
| Primary Prevention | EF ≤35% despite ≥3 months optimal medical therapy (OMT); NYHA II-III; expected survival >1 year with good functional status |
| Channelopathies | Long QT, Brugada syndrome, HCM with risk factors, ARVC |
- VT/VF detected and terminated — confirm rhythm restored on monitor
- Patient assessment: consciousness, BP, respiratory status
- 12-lead ECG immediately post-shock
- Cardiac biomarkers (troponin, CK) — repeat at 3–6 hours
- Reassure patient — explain what happened
- Report to medical team; review trigger (electrolytes, ischaemia, HF exacerbation)
- Device interrogation by EP team
- IV amiodarone 150–300 mg bolus, then 900 mg/24h infusion
- IV sedation (propofol/midazolam) to reduce sympathetic storm
- Correct electrolytes: K⁺ >4.5 mmol/L, Mg²⁺ >1 mmol/L
- Identify and treat precipitant: acute ischaemia, HF, electrolyte disturbance
- Consider applying magnet over ICD to suspend therapy temporarily while arranging treatment
- Anaesthesia support for intubation if refractory
Shocks delivered for non-life-threatening rhythms. Causes and management:
| Cause | Mechanism | Management |
|---|---|---|
| AF with fast ventricular rate | ICD detects rapid ventricular rates in AF zone, classifies as VT/VF | Rate control, reprogramming VT detection threshold |
| T-wave oversensing | Tall T-waves counted as R-waves, doubling apparent rate | Device reprogramming (sensing sensitivity adjustment) |
| Lead fracture / noise | Electrical noise from fractured lead mimics VF | Lead replacement; apply magnet temporarily |
| Sinus tachycardia | Rapid sinus rate falls in VT detection zone | Treat underlying cause (pain, infection); reprogram |
- Heart failure NYHA II–IV despite OMT
- EF ≤35%
- LBBB with QRS ≥130 ms (greatest benefit)
- Sinus rhythm preferred (evidence weaker in AF)
| Device | Function |
|---|---|
| CRT-P | CRT + pacemaker. No defibrillation. For NYHA III–IV, elderly. |
| CRT-D | CRT + ICD. Defibrillates and resynchronises. For younger patients, EF ≤35%, primary prevention. |
- LV lead placed via the coronary sinus into a lateral or postero-lateral cardiac vein
- Sub-costal access approach allows CS cannulation
- Most technically challenging component of the procedure
- LV lead most prone to dislodgement
- AV delay optimisation: Adjusts timing between atrial and ventricular pacing to maximise ventricular filling
- VV interval optimisation: Adjusts timing between RV and LV stimulation for optimal resynchronisation
- Performed 4–8 weeks post-implant via echo-guided or device-based optimisation
- Device placed subcutaneously — no transvenous leads entering the heart or veins
- Sensing lead tunnelled subcutaneously from xiphoid to left parasternal region
- Generator implanted in left lateral chest wall
- Avoids risks of transvenous approach: venous occlusion, infection on leads inside heart
- Preferred in young patients, those with congenital heart disease, or prior device infections
- Requires pre-implant ECG screening (sense vector compatibility)
- T-wave oversensing more common — requires careful programming
- No MRI conditional versions currently available (as of 2025)
- Pacing spike: narrow, vertical deflection on ECG (may be very small with modern bipolar leads)
- Atrial spike: precedes P-wave (or no visible P in atrial pacing)
- Ventricular spike: precedes wide QRS (LBBB morphology for RV apex pacing)
- DDD mode: may see both A spike → P-wave → V spike → wide QRS
- RV apex pacing produces LBBB-pattern QRS — dominant S in V1, R in V5/V6
- RVOT pacing: inferior axis QRS
- Biventricular (CRT) pacing: narrower QRS, more normal axis
What to look for
- • Pacing spikes at appropriate rate
- • Each spike followed by capture (P-wave or QRS)
- • No spikes when intrinsic beats are present (in demand mode)
- • AV interval constant in DDD mode
| Problem | ECG Finding | Common Causes | Nursing Actions |
|---|---|---|---|
| Failure to Pace | No pacing spikes when expected (intrinsic rate below programmed rate without spikes) | Battery depletion; lead fracture; lead disconnection; over-sensing inhibiting output; programming error | Check connections; increase output; check battery indicator; reduce sensitivity; call cardiology urgently if pacemaker-dependent |
| Failure to Capture | Pacing spikes present but NOT followed by P-wave or QRS | Lead dislodgement; high pacing threshold (fibrosis); output too low; electrolyte imbalance (hyperK); exit block; lead fracture | Increase output; check electrolytes; reposition patient (may help temporarily); arrange urgent device check/CXR; call cardiology |
| Failure to Sense (Under-sensing) | Pacing spikes delivered during intrinsic beats (competitive pacing — R-on-T risk) | Sensitivity set too low; lead dislodgement; intrinsic signal amplitude too small; lead fracture; programming | Increase sensitivity (reduce mV threshold); call cardiology — R-on-T can precipitate VF |
| Over-sensing | Pauses — pacing inhibited inappropriately; no spikes when intrinsic rate is low | Sensitivity set too high; T-wave oversensing; myopotentials (diaphragm, pectoral); EMI; lead fracture noise | Decrease sensitivity (increase mV threshold); remove EMI source; call cardiology; apply magnet to convert to asynchronous mode if pacemaker-dependent |
Occurs in VVI pacing when AV synchrony is lost. Retrograde VA conduction causes atria to contract against closed AV valves.
- Symptoms: palpitations, presyncope, fatigue, neck pulsations (cannon A-waves), dyspnoea
- Drop in BP ≥20 mmHg with VVI pacing compared to native rhythm
- Management: reprogram to DDD (dual chamber) to restore AV synchrony
Occurs in DDD pacemakers. Retrograde P-wave (from conducted ventricular beat) is sensed by atrial channel → triggers ventricular pacing → loop continues at upper rate limit.
- ECG: tachycardia at upper rate limit with consistent AV pacing pattern
- Management: apply magnet (converts to asynchronous — breaks re-entry loop)
- Long-term: programme PVARP extension; increase post-ventricular atrial refractory period
| Complication | Timing | Signs | Management |
|---|---|---|---|
| Lead Dislodgement | Early (<4 weeks) | Failure to pace/capture; new RBBB morphology for RV lead; CXR shows lead tip not at apex | Urgent repositioning in EP lab; bed rest; limit arm movement |
| Lead Fracture | Late (>months) | Intermittent sensing/pacing failure; noise on ECG; high impedance on interrogation | Lead replacement or extraction; avoid strenuous activity pending fix |
| Insulation Breach | Variable | Low impedance; inappropriate shocks (ICD); oversensing | Lead replacement |
| Pocket Infection | Days to months | Redness, warmth, swelling, fluctuance, discharge, fever, elevated CRP/WBC | IV antibiotics; lead extraction + device removal; reimplant contralateral side after adequate treatment |
| Device Endocarditis | Weeks to months | Fever, bacteraemia, vegetations on echo, positive blood cultures | IV antibiotics 4–6 weeks; complete lead extraction; multidisciplinary team decision on reimplantation |
| Pocket Haematoma | Early (24–72 h) | Swelling, bruising, tenderness over pocket | Manual compression; wound support; drain if tense or expanding; review anticoagulation |
| Pneumothorax | Immediate | Dyspnoea, pleuritic chest pain, reduced breath sounds, CXR confirmation | Small: observe; large/symptomatic: chest drain |
- GCC nations have high burden of cardiovascular risk factors: diabetes (prevalence 15–20%), hypertension, obesity, sedentary lifestyle — driving demand for pacing services
- Ischaemic heart disease is the leading cause of AV block requiring pacing in GCC
- Rapid population growth and expanding tertiary care infrastructure increasing implantation rates year-on-year
- Large expatriate population with varied cultural background requires nuanced communication for device acceptance and follow-up adherence
- Advanced MRI scanners widely available in tertiary hospitals across UAE, KSA, Qatar
- High frequency of MRI requests in pacemaker patients — critical that nurses document device MRI status
- Always check patient device card and confirm with EP team before any MRI request
- MRI-conditional protocol involves: EP team reprogramming, MRI team supervision, immediate post-MRI device check
- King Faisal Specialist Hospital (KFSH), Riyadh & Jeddah, KSA — pioneer cardiac EP services in GCC
- Cleveland Clinic Abu Dhabi, UAE — comprehensive EP programme including lead extraction
- Hamad Medical Corporation (HMC), Qatar — national cardiac centre, growing EP volume
- King Abdullah Medical City (KAMC), Makkah, KSA
- Mediclinic / SEHA network (UAE) — distributed pacemaker services
- King Hamad University Hospital, Bahrain
- SCFHS — Saudi Commission for Health Specialties (KSA nursing licence & exam)
- DHA — Dubai Health Authority (Dubai nursing licence)
- DOH — Department of Health Abu Dhabi (Abu Dhabi nursing licence)
- QCHP — Qatar Council for Healthcare Practitioners
- NHRA — National Health Regulatory Authority (Bahrain)
Click an answer to check. Relevant to DHA, DOH, SCFHS cardiac nursing examinations.
Pacemaker Function Analyser
Answer the questions below based on the ECG you are reviewing to determine pacemaker status and required actions.